Sebastian Zeissig

Appearances

UPADACITINIB IMPROVES SYMPTOMATIC, BIOCHEMICAL, AND INTESTINAL ULTRASOUND PARAMETERS IN ACTIVE UC PATIENTS UP TO ONE YEAR AFTER TREATMENT INDUCTION - ONE YEAR INTERIM RESULTS FROM THE IBD-DACH STUDY EUROPE
Date
May 3, 2025
Speaker
Sebastian Zeissig